These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7859744

  • 21. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade.
    Levkau B, Koyama H, Raines EW, Clurman BE, Herren B, Orth K, Roberts JM, Ross R.
    Mol Cell; 1998 Mar; 1(4):553-63. PubMed ID: 9660939
    [Abstract] [Full Text] [Related]

  • 22. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A.
    Oncogene; 1996 May 16; 12(10):2155-64. PubMed ID: 8668341
    [Abstract] [Full Text] [Related]

  • 23. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
    Green SL, Freiberg RA, Giaccia AJ.
    Mol Cell Biol; 2001 Feb 16; 21(4):1196-206. PubMed ID: 11158306
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ, Yan S, Herr KD, Wenner CE.
    Cancer Res; 1995 Apr 01; 55(7):1413-6. PubMed ID: 7882344
    [Abstract] [Full Text] [Related]

  • 25. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar 01; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 26. Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
    Aprelikova O, Xiong Y, Liu ET.
    J Biol Chem; 1995 Aug 04; 270(31):18195-7. PubMed ID: 7629134
    [Abstract] [Full Text] [Related]

  • 27. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A.
    J Cell Physiol; 2003 Apr 04; 195(1):139-50. PubMed ID: 12599217
    [Abstract] [Full Text] [Related]

  • 28. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H.
    J Biol Chem; 2000 Oct 06; 275(40):31145-54. PubMed ID: 10878006
    [Abstract] [Full Text] [Related]

  • 29. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
    Kwon TK, Nordin AA.
    Oncogene; 1998 Feb 12; 16(6):755-62. PubMed ID: 9488039
    [Abstract] [Full Text] [Related]

  • 30. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Reynisdóttir I, Polyak K, Iavarone A, Massagué J.
    Genes Dev; 1995 Aug 01; 9(15):1831-45. PubMed ID: 7649471
    [Abstract] [Full Text] [Related]

  • 31. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor.
    Goubin F, Ducommun B.
    Oncogene; 1995 Jun 15; 10(12):2281-7. PubMed ID: 7784076
    [Abstract] [Full Text] [Related]

  • 32. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 33. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells.
    Baldassarre G, Belletti B, Bruni P, Boccia A, Trapasso F, Pentimalli F, Barone MV, Chiappetta G, Vento MT, Spiezia S, Fusco A, Viglietto G.
    J Clin Invest; 1999 Oct 06; 104(7):865-74. PubMed ID: 10510327
    [Abstract] [Full Text] [Related]

  • 34. Caco-2 intestinal cell differentiation is associated with G1 arrest and suppression of CDK2 and CDK4.
    Ding QM, Ko TC, Evers BM.
    Am J Physiol; 1998 Nov 06; 275(5):C1193-200. PubMed ID: 9814966
    [Abstract] [Full Text] [Related]

  • 35. Regulation of nuclear transport and degradation of the Xenopus cyclin-dependent kinase inhibitor, p27Xic1.
    Chuang LC, Yew PR.
    J Biol Chem; 2001 Jan 12; 276(2):1610-7. PubMed ID: 11044455
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.
    Smith E, Redman RA, Logg CR, Coetzee GA, Kasahara N, Frenkel B.
    J Biol Chem; 2000 Jun 30; 275(26):19992-20001. PubMed ID: 10867026
    [Abstract] [Full Text] [Related]

  • 37. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):9042-6. PubMed ID: 10908655
    [Abstract] [Full Text] [Related]

  • 38. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
    Lee MH, Reynisdóttir I, Massagué J.
    Genes Dev; 1995 Mar 15; 9(6):639-49. PubMed ID: 7729683
    [Abstract] [Full Text] [Related]

  • 39. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.
    EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686
    [Abstract] [Full Text] [Related]

  • 40. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.